A preliminary cost-effectiveness analysis of a two-dose measles-mumps-rubella-varicella (MMRV) vaccine in France

B. Dervaux, X. Lenne and N. Largeron
Additional contact information
B. Dervaux: LEM - Lille - Economie et Management - Université de Lille, Sciences et Technologies - CNRS - Centre National de la Recherche Scientifique
X. Lenne: LEM - Lille - Economie et Management - Université de Lille, Sciences et Technologies - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Date: 2006-05-03
References: Add references at CitEc
Citations:

Published in Communication affichée au 24rd Annual Meeting of the European Society for Paediatric Infectious Diseases – ESPID., May 2006, Bale, Switzerland

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-00226385

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().